Researchers have developed a new way to grow mineralized materials which could regenerate hard tissues such as dental enamel and bone. Enamel, located on the outer part of our teeth, is the hardest tissue in the body and enables our teeth to function for a large part of our lifetime despite biting forces, exposure to acidic foods and drinks and extreme temperatures. The study was published in Nature Communications.
All news from Anaesthesiology
The brains of transgender individuals share characteristics with those of the gender they identify with, according to new research. Researchers used MRI scans to identify brains response to a pheromone that men and women are known to react to differently.
Human beings may face many circumstances, such as surgery, trauma, and anemia, in which they could require an urgent blood transfusion. However, only a few studies have examined people’s risk perception of blood transfusion.
Helene Egvang has suffered from bipolar disorder since she was 17. A large part of her life swings between depression and mania. The worst situation is where a deep depression accompanies mania. It is at these times that she is most often admitted to hospital.
The US Food and Drug Administration (FDA) says it continues to receive reports of surgical fires, which can result in burns, other serious injuries, disfigurement, and death. Such fires are mostly preventable.
RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology (QST), a pioneer of ion beam technology based in Chiba, Japan.
Massive phytoplankton proliferation and the consequent release of toxic metabolites can be responsible for seafood poisoning outbreaks: filter-feeding mollusks, such as shellfish, mussels, oysters or clams, can accumulate these toxins throughout the food chain and present a threat for consumers’ health.
A rare opportunity to analyze both blood and tissue samples from human transplant recipients has allowed immunology researchers at the Babraham Institute to pinpoint how an immunosuppressive drug works to prevent the production of antibodies against the transplanted tissue.
A new approach pioneered at the University of Pennsylvania's Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. To treat AML, investigators have to target a specific protein, CD33